E-drug: Conference announcement
Here is the final announcement of the conference on ethics and
economics in pharmacotherapy.
Hana Muellerova, PhD
Dept. Social&Clinical Pharmacy
Hradec Kralove 50005
fax - +420/49/5210002
ETHICAL AND ECONOMICAL ASPECTS OF
June, 4 - 6, 1998 in Hradec Kr lov?, Czech Republic
8.30 Opening (J.Vlcek, E.Kvasnickov , L.Pr znovcov ; J.
Lectures I - chairmen: R. Dessing, L. Pr znovcov ,
9.00 Merrills J (UK): An introduction to ethics and economics
9.30 Kouteck J (Czech Republic): Ethical problems from the
point of view of physicians
9.55 Sado (F): Clinical trials
10.20 Ch. Byk (France - CIOMS)): Drugs and the European
Legislation Policy: developing the market and safety
needed in public health
11.45 Coffee break
12.00 J. Payn (Czech Republic): Informed consent: Its structure
and role in modern medicine
12.25 A. Edgar (UK) :"Teaching of ethics, focusing on the
12.50 Lunch Discussion
14.00 Workshops 1 - 6
16.00 Coffee break - poster discussion
16.30 Lectures II - chairmen: B. Leufkens, J. Netocn
16.35 R. Walker (UK): Can we afford the medicines we need -
an ethical dilemma
16.55 CB Claesson (Sweden): Drug choice and ethical dilemma
16.40 A. Hartzema (USA North Caroline): Practice guidelines:
the economics of evidence based clinical decisions.
17.30 Gottler M., Scheenweiss S., Hasfors J (Germany )> Cost
and preventability of adverse drug reactions leading to
17.45 Bovy K., R. Vanden Stichele, Bogaert M.(Belgium)
Management of severe pediatric cancer pain in Flemish
18.00 Prymula R (CZ)
9.00 Lectures III - chairmen B. Hartzema, J. Vleek, S. Salek
9.00 B. Leufkens (The Netherlands): 'The interplay between
drug and patient / factors in evaluating patient outcomes
of drug therapy'?
9.25 L.Bootman (USA): Economics of drug related morbidity
and Mortality in ambulatory, acute care and long term
9.50 S.Salek (UK) "Health-Related Quality of Life (HRQoL)
and Pharmacotherapeutic outcomes: Practical and
Methodological Issues for Teaching and Research"
10.15 Coffee break - poster discussion
10.45 R. Dessing (The Netherlands) - Ethics in pharmacy -
what is the reality
11.15 M.Schaefer (Germany): Quality of Life in Pharmaceutical
11.30 Discussion of last two lectures
11.40 J.Lilja (Finland) : Ethical values in pharmacotherapy
and pharmacoeconomics -With examples from the field
12.05 G. Carstens (Germany)): Economical and ethical aspects
of cancer therapy
12.30 Reinstein JA (UK): Ethical promotion and advertising -
what does it mean and how can it be controlled?
14.15 Workshops 1 - 6
16.00 Coffee break
Lecture IV - chairman: R. Walker
16.30 J. Cvihovec, J. Blaho : Ethical and economical problems
of drug categorisation for drug reimbursement
17.20 Round table discussion
chair - R. Walker, J Cvihovec (authorities), A. Hartzema
scientist); Reinstein JA, (industry), R. Dessing
(pharmacist), C. Anderson (inter-professional relations)
18.20 Conclusion of symposium
20.30 Farewell dinner in Alexandria
1/ R. Walker: Managing the entry of new drugs
2/ A. Edgard; S. Salek: Ethical aspects of QALYs
3/ L. Bootman: Pharmacoeconomic education for
4/ G. Carstens: Economical and ethical aspects of cancer
5/ A. Hartzema: Health related-QoL instrumentation.
6/ C. Anderson (UK): Interface between physicians and
Third day - 6.6.1998 Praha - Carolinum sight seeing
Detailed information (including full programme) is available on
home page: http://www.faf.cuni.cz/
Symposium Secretariat - registration:
Ethical and Economical Aspects of Pharmacotherapy
Czech Medical Association J. E. Purkyn?
P. O. Box 88, Sokolsk 31, CZ - 120 26 Prague 2
Phone: + 420 2 297 271, + 420 2 2491 5195
Fax: + 420 2 294 610, + 420 2 2421 6836
Late (after May 1)
Full participant 450 DM
Student 200 DM
Accompanying person 150 DM
Send mail for the `E-Drug' conference to `email@example.com'.
Mail administrative requests to `firstname.lastname@example.org'.
For additional assistance, send mail to: `email@example.com'.